tiprankstipranks
Trending News
More News >
Advertisement

GB:CYBO ETF Technical Analysis

Compare

Summary of all the Indicators

Summary
Sell
7Bullish
5Neutral
10Bearish
Oscillators
Buy
4Bullish
5Neutral
1Bearish
Moving Averages
Strong Sell
3Bullish
0Neutral
9Bearish
VanEck Bionic Engineering UCITS ETF Accum -A- USD’s (CYBO) Moving Averages Convergence Divergence (MACD) indicator is 0.04, suggesting VanEck Bionic Engineering UCITS ETF Accum -A- USD is a Buy.
VanEck Bionic Engineering UCITS ETF Accum -A- USD’s (CYBO) 20-Day exponential moving average is 20.56, making it a Sell.
VanEck Bionic Engineering UCITS ETF Accum -A- USD’s (CYBO) 50-Day exponential moving average is 20.42, making it a Buy.

VanEck Bionic Engineering UCITS ETF Accum -A- USD (CYBO) Pivot Points

Jul 18, 2025, 06:24 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
20.87
20.87
20.87
20.87
20.87
20.87
20.87
Fibonacci
20.87
20.87
20.87
20.87
20.87
20.87
20.87

VanEck Bionic Engineering UCITS ETF Accum -A- USD (CYBO) Moving Averages

Jul 18, 2025, 06:24 AM
Period
Simple
Exponential
MA5
20.56Sell
20.58Sell
MA10
20.62Sell
20.58Sell
MA20
20.51Sell
20.56Sell
MA50
20.49Sell
20.42Buy
MA100
20.12Buy
20.38Buy
MA200
20.60Sell
20.59Sell
VanEck Bionic Engineering UCITS ETF Accum -A- USD’s (CYBO) 10-Day exponential moving average is 20.58, making it a Sell.
VanEck Bionic Engineering UCITS ETF Accum -A- USD’s (CYBO) 100-Day exponential moving average is 20.38, making it a Buy.
VanEck Bionic Engineering UCITS ETF Accum -A- USD’s (CYBO) 50-day simple moving average is 20.49, creating a Sell signal.
VanEck Bionic Engineering UCITS ETF Accum -A- USD’s (CYBO) 100-day simple moving average is 20.12, creating a Buy signal.
VanEck Bionic Engineering UCITS ETF Accum -A- USD’s (CYBO) 200-day simple moving average is 20.60, creating a Sell signal.

VanEck Bionic Engineering UCITS ETF Accum -A- USD (CYBO) Technical Analysis

Jul 18, 2025, 06:24 AM
Name
Value
Action
RSI (14)
47.65
Neutral
STOCH (9,6)
33.72
Neutral
STOCHRSI (14)
51.00
Neutral
MACD (12,26)
0.04
Buy
ADX (14)
10.86
Buy
Williams %R
-101.18
Buy
CCI (14)
-27.84
Neutral
ATR (14)
0.15
-
Ultimate Oscillator
42.98
Neutral
ROC
1.09
Buy
VanEck Bionic Engineering UCITS ETF Accum -A- USD’s (CYBO) Relative Strength Index (RSI) is 47.65, creating a Neutral signal.
VanEck Bionic Engineering UCITS ETF Accum -A- USD’s (CYBO) Trend Strength Indicator (ADX) is 10.86, creating a Buy signal.
VanEck Bionic Engineering UCITS ETF Accum -A- USD’s (CYBO) Commodity Channel Index (CCI) is -27.84, creating a Neutral signal.
VanEck Bionic Engineering UCITS ETF Accum -A- USD’s (CYBO) Price Rate of Change (ROC) is 1.09, creating a Buy signal.

FAQ

Is CYBO a Buy, Hold, or Sell?
Based on CYBO’s technical indicators, CYBO is a Sell.
    What is CYBO’s RSI (14)?
    CYBO’s RSI (14) is 47.65, which suggests CYBO is a Neutral.
      What is CYBO’s MACD?
      CYBO’s MACD is 0.04, which suggests CYBO is a Buy.
        What is CYBO’s 5-day moving average?
        CYBO’s 5-day moving average is 20.56, which suggests CYBO is a Sell.
          What is CYBO’s 20-day moving average?
          CYBO 20-day moving average is 20.51, which suggests CYBO is a Sell.
            What is CYBO’s 50-day moving average?
            CYBO’s 50-day moving average is 20.49, which suggests CYBO is a Sell.
              What is CYBO’s 200-day moving average?
              CYBO’s 200-day moving average is 20.60, which suggests CYBO is a Sell.
                What is CYBO’s Williams % R (14)?
                CYBO’s Williams % R (14) is -101.18, which suggests CYBO is a Buy.
                  What is CYBO’s CCI (14)?
                  CYBO’s CCI (14) is -27.84, which suggests CYBO is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis
                    Advertisement